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Abstract
Background: One approach to preventing opioid overdose, a leading cause of premature, preventable mortality,
is to provide overdose education and naloxone distribution (OEND). Two outstanding issues for OEND
implementation include 1) the dissemination of OEND training from trained to untrained community members;
and 2) the concern that OEND provides active substance users with a false sense of security resulting in increased
opioid use.
Methods: To compare overdose rescue behaviors between trained and untrained rescuers among people
reporting naloxone rescue kit use; and determine whether heroin use changed after OEND, we conducted a
retrospective cohort study among substance users in the Massachusetts OEND program from 2006 to 2010. We
used chi square and t-test statistics to compare the differences in overdose management characteristics among
overdoses managed by trained versus untrained participants. We employed Wilcoxon signed rank test to compare
median difference among two repeated measures of substance use among participants with drug use information
collected more than once.
Results: Among 4,926 substance-using participants, 295 trained and 78 untrained participants reported one or more
rescues, resulting in 599 rescue reports. We found no statistically significant differences in help-seeking (p =0.41), rescue
breathing (p =0.54), staying with the victim (p =0.84) or in the success of naloxone administration (p =0.69) by trained
versus untrained rescuers. We identified 325 OEND participants who had drug use information collected more than
once. We found no significant overall change in the number of days using heroin in past 30 days (decreased 38%,
increased 35%, did not change 27%, p =0.52).
Conclusion: Among 4926 substance users who participated in OEND, 373(7.6%) reported administering naloxone
during an overdose rescue. We found few differences in behavior between trained and untrained overdose rescuers.
Prospective studies will be needed to determine the optimal level of training and whether naloxone rescue kits can
meet an over-the-counter standard. With no clear evidence of increased heroin use, this concern should not impede
expansion of OEND programs or policies that support them.
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Drug overdose is a leading cause of premature, prevent-
able mortality. In the United States, poisoning - 9 of 10 of
which are drug overdoses - has surpassed motor vehicle
crashes to become the leading cause of injury death [1,2].
In Massachusetts, USA, opioid related overdose exceeds
motor vehicle crashes as the leading cause of injury death
[3]. Drug overdose is also a major cause of mortality in
Canada [4,5], Europe [6], Asia [7,8], and Australia [9].
One approach to opioid overdose prevention is to pro-
vide naloxone rescue kits to drug users. Naloxone is an
opioid antagonist that has no abuse potential and reverses
the effects of respiratory depression and decreased con-
sciousness during an opioid overdose. Naloxone can be
provided by prescription during the regular course of
medical care [10-13], by pharmacist-initiated collaborative
practice agreement [14], or by community-based overdose
education with naloxone distribution (OEND) programs
[15-26]. These programs target people who are at risk of
opioid overdose and/or likely to be bystanders during an
overdose to educate them on how to prevent an overdose
from occurring, and to prevent opioid related over intoxi-
cation from progressing to a fatal overdose by seeking
help, rescue breathing and administering naloxone. Be-
tween 1996 and 2010, over 50,000 potential bystanders
were trained by OEND programs in the United States
resulting in over 10,000 opioid overdoses reversed with
naloxone [27]. The promise of this intervention has been
recognized through endorsements by the United Nations
Office on Drugs and Crime (UNODC) jointly with the
World Health Organization (WHO) [28] US President’s
Emergency Plan For AIDS Relief (PEPFAR) [29], the
American Public Health Association (APHA) [30],
state legislatures, public health departments and na-
tional programs [31]. We published an interrupted time-
series analysis of the Massachusetts OEND program that
demonstrated decreased opioid overdose death rates in
communities that had implemented OEND compared to
communities that had not, controlling for community
level factors [32]. A simulation study of naloxone distribu-
tion to heroin users using conservative assumptions found
an increase in Quality Adjusted Life Years (QALYs) and
that naloxone distribution is cost-effective [33].
OEND programs have primarily been implemented among
substance users who are at risk for overdose themselves
and are likely to witness another person overdosing, and
thus are in the position to help. While numerous studies
have shown that trained laypersons are capable of rec-
ognizing and responding to opioid overdose events
[16,19-24,26,32,34-36], the minimum length and content
of these trainings is yet to be established. Trainings in
these studies range from 5 minutes [32] to 8 hours [24].
Opinions about the right level of training range from
the belief that naloxone rescue kits should be available
over the counter without any mandated training [37], to
the belief that an opioid overdose requires trained med-
ical intervention and is not appropriate for layperson by-
stander response [38,39]. Once naloxone rescue kits are
distributed into the community to people trained in
overdose prevention, they are further disseminated
through social networks to people who were not trained
directly by the distribution programs (untrained). Whether
these untrained potential bystanders successfully respond
to overdoses with naloxoner e s c u ek i t si sn o tk n o w n .
Clinicians, policy makers, and researchers have debated
if providing people who use drugs with the skills to
recognize and respond and the medicine (naloxone) to re-
verse opioid related overdoses, may increase opioid use or
delay entry into addiction treatment by reducing interac-
tions with emergency health care providers and the risk of
adverse consequences of using drugs [38,40-43]. Although
one prospective survey (N =82) among people who inject
drugs (PWID) found that 35% of respondents anticipated
that he or she would feel comfortable using more heroin
after receiving a naloxone rescue kit [44], no studies of
existing OEND programs have demonstrated increased
drug use by participants. One small study among PWID
trained in OEND (N =24) reported statistically significant
decreases in heroin injection at 6-month follow-up [24],
one (N =47) reported that 53% of trained substance users
decreased drug use at 3 months [26], and another among
trained substance users (N =22) reported no difference in
drug use at follow-up [45].
Since 2006, the Massachusetts Department of Public
Health’s Opioid Overdose Prevention Pilot program has
provided OEND to potential overdose bystanders in nu-
merous communities through local organizations providing
varied types of services (e.g., HIV risk reduction services,
outreach and case management, addiction treatment). Ap-
proximately two-thirds of the program participants have
self-identified as a current or former drug user. In the
current study, we sought to inform these two issues of
whether “untrained” overdose bystanders can successfully
respond to overdoses and how heroin use changes before
and after training by using data reported by substance-
using OEND program participants, including follow-up
overdose rescue events and substance use data. The aims
of this study were 1) to compare the management of over-
dose events by untrained rescuers to those by trained res-
cuers among people reporting naloxone rescue kit use; and
2) to assess how opioid use changed after receiving OEND
at a large multisite OEND program in Massachusetts,
United States over nearly five years.
Methods
Program description
In 2006, public health programs in Boston and Cambridge
began providing overdose education and distributing
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Massachusetts Department of Public Health (MDPH), via
a collaboration among public health and policy practi-
tioners from the Commissioner’s Office, the Bureau of
Substance Abuse Services and Office of HIV/AIDS, ex-
panded OEND services to a total of eight agencies by
2010. The agencies provided regular individual and group
OEND training sessions to potential opioid overdose by-
standers via trained non-medical public health workers
under a standing order from the program’sM e d i c a l
Director. Settings include integrated public health preven-
tion and screening programs for HIV, STIs, and viral
hepatitis including needle exchange, low-threshold multi-
service community service centers for injection drug
users, detoxification programs, methadone maintenance
treatment programs, other outpatient and residential ad-
diction treatment programs, community meetings, emer-
gency departments, homeless shelters, and home visits.
The OEND agencies, the medical director, the MDPH,
and subject area experts held monthly teleconferences on
safety and quality assurance and met in person quarterly
for quality improvement including data quality, inter-
agency strategy transfer, and protocol and policy review.
Periodic site visits by a master trainer occurred to ensure
staff was sufficiently trained.
The MDPH OEND program uses the core compo-
nents of the Skills and Knowledge on Overdose Preven-
tion (SKOOP) training curriculum adapted for intranasal
naloxone, originally developed by the Harm Reduction
Coalition, and also incorporates elements of training de-
veloped by Chicago Recovery Alliance and the Drug
Overdose Prevention and Education (DOPE) Project
[20]. The curriculum [46] is delivered by trained non-
medical agency staff who must complete a four-hour
course, a knowledge test and two trainings of potential
bystanders supervised by a master trainer. The curriculum
includes techniques in overdose prevention (i.e. minimiz-
ing polysubstance use, awareness of tolerance change) and
management, such as how to assess for overdose, seek
help, deliver rescue breathing, administer intranasal nalox-
one, post administration support, and specific techniques
to avoid. Participants receive a naloxone rescue kit that in-
cludes instructions, two luer-lock, prefilled syringes with
2 mg/2 mL naloxone hydrochloride, and two mucosal
atomization devices. Enrolled participants are instructed
to deliver 1 mL (1 mg) to each nostril of the overdose vic-
tim. The second dose of naloxone in a rescue kit has dual
roles. The first is that one dose may be insufficient for re-
sponse if particularly strong opioids are involved in the
overdose, such as unusually strong heroin or heroin adul-
terated with fentanyl. Secondly, because most opioid ago-
nists have a longer half-life than naloxone, if overdose
symptoms return, victims can be treated with the second
dose. Depending on the enrollee’s previous experience and
knowledge of overdose, the setting and the number of
people being trained, trainings are provided in groups (no
more than 10 people per staff member) or individually
and can last between 5 and 60 minutes.
The program offers refills to participants on request.
At the time of refill request, program staff collects data
on the reason for the refill request and, if the program
naloxone was used during an overdose rescue attempt,
details about the overdose rescue.
Study design and population
We conducted a retrospective cohort study using pro-
gram data from the Massachusetts Opioid Overdose
Prevention Pilot program among participants who re-
ported any substance use in the 30 days prior to enroll-
ment (N =4,926). This program and sample have been
described previously [32,47].
The training analysis (aim 1, N =373, Figure 1) was
conducted at the overdose rescue event level. We com-
pared overdose rescues reported by people who were
formally trained by OEND staff prior to reporting the
rescue to those events reported by people who were
trained by OEND staff at the time of rescue report, thus
untrained by OEND staff at the time of overdose rescue.
The untrained rescuers obtained the naloxone through
social networks. Knowledge transfer about using naloxone
at the time of obtaining naloxone from social network
members ranges from none or minimal (for example: a
rescuer who discovered an overdose victim and found
the naloxone on the victim’s person) to extensive (for
example: drug using partners who had discussed an
overdose plan prior to an overdose event).
For the opioid use analysis (aim 2, N =325, Figure 1),
we restricted the study sample to program participants
from whom we collected substance use information more
than once between September 18, 2006 and December 31,
2010 because he or she was re-enrolled. These participants
reported on their 30-day substance use at two or more
time points, separated by at least 30 days.
Data collection and measures
At enrollment, program staff created a unique program
identifier for participants based on his or her birth date,
the first three letters of his or her mother’s first name,
first and third letter of his or her first and last names.
Full names and addresses were not collected. This pro-
gram identifier, in combination with age, gender and
race, was used to eliminate duplicate enrollments and
link enrollment and refill records. OEND staff also com-
pleted a questionnaire that included the participant’s
demographics, lifetime overdose history, 30 day sub-
stance use history (number of days used out of the last
30 days), and 12 month detoxification program use. For
substance use, route of administration was not asked.
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questionnaire that included the reason for requesting a
refill and, if it was because naloxone was used during an
overdose rescue, questions about the overdose.
For aim 1, we used refill-rescue questionnaires admin-
istered by OEND staff when participants who presented
to program sites to report an overdose rescue and re-
quest a naloxone rescue kit refill. (Figure 1) Staff was
trained to define an overdose as an episode when an un-
responsive victim had signs of respiratory depression
after using substances. Other variables included in the
refill-rescue questionnaire were used to describe over-
dose event characteristics; describe adherence to specific
OEND training components, and; assess differences in
the overdose events managed by the formally trained
and untrained group. Overdose characteristic descriptive
measures included: the relationship to the person who
overdosed, the setting (public or private), the number of
naloxone doses used, and whether naloxone was suc-
cessful. Naloxone administration was considered suc-
cessful if the victim’s unresponsiveness and respiratory
depression improved and the person survived. Overdose
response items on the questionnaire that we defined as
adherent to OEND training were sternal rub (assess for
overdose), 911 called (seek help), rescue breathing, ad-
minister naloxone, staying with victim (post naloxone
support). Overdose response items on the questionnaire
that we defined as non-adherent to OEND training tech-
niques were slap, ice/water applied, and salt/cocaine injection.
We examined the dates of the enrollment and refill ques-
tionnaires to identify the subset of program participants
who were not trained by OEND staff prior to an overdose
rescue. (Figure 1) Participants who reported administering
naloxone during an overdose rescue attempt, but who had
not previously completed an enrollment form, were de-
fined as untrained at the time of the rescue attempt.
Those who reported administering naloxone during a res-
cue attempt who had been enrolled previously were de-
fined as trained. Any subsequent rescue reports by people
who were untrained at the time of first report were trans-
ferred to the trained category, as the standard practice at
each site was to enroll and train participants at the time of
the first rescue report, if they had not been previously
enrolled.
For aim 2, we used pairs of enrollment questionnaires
completed by participants who had been enrolled in
OEND more than once separated by at least 30 days.
(Figure 1) These “repeat enrollments” occurred because
OEND services were delivered by eight agencies, none of
which shared lists of enrollment codes. Thus, staff at
one program did not know if the participant completed
the enrollment questionnaire at another site, so when an
individual presented for the first time at an agency for
OEND services, an enrollment questionnaire was com-
pleted regardless of whether the individual had previ-
ously enrolled at another site. Additionally, when OEND
services were provided during outreach, a staff person
might not have access to the participant code list to de-
termine if the program participant had been enrolled.
Therefore, the staff re-enrolled participants whose en-
rollment status was uncertain, creating a subset of repeat
enrollers from whom information was collected more
Total OEND program 
participants
N=8,664
Substance use collected 
once
N=4,601
(Data not shown)
Substance use collected 
more than once
N=325
(Table 3 & Fig 2)
Reported ≥ 1 OD rescue before
OEND enrollment (untrained)
N=78
(Table 2)
Reported ≥ 1 OD rescue after
OEND enrollment (trained)
N=295
(Table 2)
No reported overdose rescue
Excluded from rescue
analysis only 
N=4,553
OEND participants reporting 
any substance use, past 30 
days
N=4,926
(Table 1)
No reported substance use
Excluded from all analyses
N=3,738
Figure 1 Flow diagram of study participants.
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substance use behavior in the time period preceding re-
ceiving OEND services the first time, as well as, a later
time period after having received training and a nalox-
one rescue kit.
To examine frequency of use for each individual
substance (heroin, benzodiazepine/barbiturate, cocaine,
methadone, alcohol, buprenorphine, and other opioids),
we created the following four categories from the enroll-
ment questionnaire: those reporting no use in the past
30 days; 1–10 days of use out of the past 30; 11–20 days
of use and; 21–30 days of use. We created a measure of
number of substances used in previous 30-day period,
defined as the sum of the number of substances (heroin,
methadone, buprenorphine, other opioids, cocaine, alco-
hol, benzodiazepine/barbiturate and methamphetamine)
that respondents reported consuming at least one day
out of the past 30 days. We further categorized number
of substances used as increased when a person reported
a higher number at the second enrollment, compared to
the first enrollment; decreased when a person reported a
lower number at second enrollment compared to first
enrollment, and; no change when the number of sub-
stances used stayed the same. We also measured the
time between enrollments.
This study was approved by the Institutional Review
Boards of Boston University and the Massachusetts De-
partment of Public Health. This study uses de-identified
existing program data and written informed consent was
not obtained. Cells with a count of 5 or less have been
suppressed as an identity protection measure.
Analysis
Data from enrollment and refill questionnaires collected
by the eight agencies were stored and maintained in a
central MDPH OEND program database. From this
database, we derived a de-identified dataset from which
means, frequencies and proportions were calculated
using SAS version 9.3 statistical software.
For the analyses for aim 1, we employed t-tests for
continuous variables and chi square tests for categorical
variables to assess the difference between participants
who never rescued, those that rescued after enrollment
(trained) and those that rescued before enrollment (un-
trained), as well as, to assess the difference between
overdose rescue characteristics between those managed
by trained versus untrained program participants.
For the analyses for aim 2, we used t-tests for continu-
ous variables and chi square tests for categorical vari-
ables to assess the difference between repeat enrollers
and one-time enrollers. To compare substance use
among repeat enrollers at first and second enrollment,
we employed the Wilcoxon signed rank test to compare
the median difference of the number of days of each
substance use and the number of substances used be-
tween two repeated measures of the repeat enrollers
sample. As part of a sensitivity analysis to determine
whether the time between enrollments was a predictor
of drug use at second enrollment, we used linear regres-
sion analysis with days of use at second enrollment as
the dependent variable and days of use at first enrolment
and time between enrollments as independent variables.
Results
Characteristics of the study population
Between September 18, 2006 and December 31, 2010,
8,664 participants were trained to prevent, recognize
and respond to an overdose, including receiving a nalox-
one rescue kit. We excluded 3,738 participants who did
not report any substance use at any enrollment. Of the
4,926 participants who reported any substance use,
4,553 (92.4%) never reported an overdose rescue, 295
(6.0%) trained participants reported at least one rescue
and 78 (1.6%) untrained participants reported at least
one rescue with naloxone prior to being enrolled in the
OEND (Table 1).
Prevalence of overdose risk factors including home-
lessness, polysubstance use, tolerance changes associated
with supervised withdrawal procedures (detox) and in-
carceration, previous nonfatal overdose and lifetime wit-
ness of overdose were present in both participants who
reported rescues and those who did not at similar rates.
Participants who reported a rescue were less likely to
have attended detox in the previous year (p <0.001) and
more likely to have had a nonfatal overdose (p <0.001)
and to have witnessed at least one overdose (p <0.001).
Participants who reported a rescue were more likely to
report using only heroin than the participants who never
reported a rescue (p <0.001). Participants who did not
report a rescue were more likely to be enrolled at a de-
tox location, while those who did report a rescue were
more like to have been enrolled at needle exchange pro-
grams or drop-in centers for PWID (p <0.001).
Characteristics of one-time enrollers (n = 4,601) and
repeat enrollers (the subset of 325 participants who had
at least two enrollments that were separated by at least
30 days- Figure 1) were similar, though repeat enrollers
were more likely than one-time enrollers to have attended
detox in the past year (70% vs 62%, p <0.001), have a
personal history of overdose (63% vs 51%, p <0.001),
and report an overdose rescue using program naloxone
(17% vs 7%, p < 0.001). (Data not shown).
Overdose rescues by trained vs. untrained rescuers
Of the 373 substance-using OEND program participants
who reported an overdose rescue (Figure 1), 34% of the
trained and 24% of the untrained participants reported
more than one overdose rescue with a mean of 2.9 and
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group respectively (Table 1) for a total of 599 overdose
rescue events using OEND program naloxone. (Table 2)
Most (67% & 69%, p =0.92 for trained and untrained
rescuers, respectively) of the overdose victims were
friends of the rescuer. Overdoses most commonly oc-
curred in a private setting (79% & 70%, p =0.13 for
trained and untrained rescuers, respectively) and were
successfully managed with only one dose of naloxone
(52% & 61%, p =0.06 for trained and untrained rescuers,
respectively). About half of the time the victim received
rescue breathing (47% & 52%, p =0.54 for trained and
untrained rescuers, respectively) and about one quarter
of the time, 911 was called or emergency medical ser-
vices were present (23% & 27%, p =0.41 for trained and
untrained rescuers, respectively). Most of the rescuers
stayed with the victim and/or turned care over to emer-
gency medical professionals (89% & 89%, p = 0.84 for
trained and untrained rescuers, respectively). The most
common form of stimulation that the rescuer performed
was a sternal rub – a recommended technique in OEND
training– followed by slapping and applying ice or cold
water, which were discussed during training and not rec-
ommended. None of the rescuers reported injecting salt
water or cocaine.
We found no statistically significant differences in the
overdose event characteristics or actions taken during
the overdose where the rescuer was previously trained
by OEND staff compared to the events where the rescuer
was not previously trained.
Changes in opioid use among participants enrolled more
than once
The mean number of days between the first enrollment
and the second enrollment was 364 (median 288), with a
maximum of 1473 and a minimum of 30 days between
the times of information collection.
Table 1 Characteristics of overdose education and naloxone distribution program participants who reported any
substance use, Massachusetts, 2006-2010
No rescue reported Trained rescuers Untrained rescuers
N =4553 N =295 N =78
Age mean (std dev) 34.1 (10.8) 35.1 (10.6) 35.0 (10.3)
Female and MtF 35% (1579/4479) 34% (99/289) 42% (33/78)
Race/Ethnicity
Hispanic 14% (643/4511) 11% (31/293) 17% (13/78)
White, Non-Hispanic 77% (3463/4511) 80% (235/293) 81% (63/78)
Black/African American, Non-Hispanic 5.5% (249/4511) 6.1% (18/293) **
Other, Non-Hispanic 3.5% (156/4511) 3.1% (9/293) **
Enrollment location type
Inpatient detoxification 42% (1554/3730) 24% (35/144) 21% (13/61)
Needle exchange 17% (635/3730) 31% (45/144) 41% (25/61)
Drop-in center 13% (503/3730) 26% (37/144) 33% (20/61)
Other 28% (1038/3730) 19% (27/144) **
Opioid use, previous 30 days
Heroin only 48% (2199/4553) 60% (181/295) 72% (56/78)
Any other opioid 30% (1372/4553) 27% (81/295) 22% (15/78)
No opioid use 22% (982/4553) 13% (38/295) **
Polysubstance use, previous 30 days 77% (3515/4553) 80% (235/295) 79% (62/78)
Attended detoxification, past year 63% (2769/4397) 53% (146/278) 55% (41/75)
Released from incarceration, past year 26% (1140/4389) 29% (80/275) 16% (12/75)
Any homelessness, past year 37% (1592/4291) 38% (102/272) 38% (28/74)
Ever had a nonfatal overdose 51% (2248/4425) 63% (178/281) 68% (51/75)
Ever witnessed an overdose 76% (3378/4464) 86% (249/288) 94% (72/77)
Reported >1 overdose rescue – 34% (101/295) 24% (19/78)
mean (std dev) 2.9 (1.6) 2.6 (1.3)
Denominators less than the total number for each group are due to missing information.
**Cells with values less than 5 suppressed.
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heroin was the substance used most commonly with
70% reporting any heroin use in the past 30 days, and
42% reporting heroin use in at least 21 of the last
30 days. (Figure 2) Less than half reported using benzo-
diazepines/ barbiturates (45%), cocaine (41%), metha-
done (40%), alcohol (31%), buprenorphine (27%), or
other opioids (24%). Among people who reported taking
methadone, at least 21 days of use was common, whereas
among participants who reported any use of other sub-
stances, most participants used 1–10 days out of the
last 30 days. These patterns of use were similar for
those who were one-time enrollers and for the first and
second enrollment among the multiple enrollers (data
not shown).
Among the 325 participants from whom 30 day sub-
stance use data were collected twice, 38% had decreased
days using heroin and 35% had increased days using her-
oin. (Table 3) More participants decreased the number
of days of heroin (38% v 35%, p = 0.52), other opioids
(19% v 18%, p =0.51), cocaine (30% v 26%, p =0.41),
and alcohol (22% v 21%, p =0.86) use than increased,
though these findings were not statistically significant.
More participants increased the days of methadone (26%
v 22%, p =0.72) and buprenorphine (22% v 20%, p =0.31)
than decreased, though this was not statistically signifi-
cant. There was a statistically significant difference in
participants who increased than decreased days using
benzodiazepine/barbiturates (30% v 23%, p =0.004).
Forty per cent increased the number of substances used
in the past 30 days, 38% decreased the number of sub-
stances, and 21% reported no change (p = 0.65). Time
between enrollments was not a significant predictor of
drug use at second enrollment (data not shown).
Discussion
This study describes the implementation of a large pub-
lic health department-sponsored overdose education and
intranasal naloxone distribution program among 4,926
Massachusetts participants who reported substance use
at enrollment. We found no significant evidence of differ-
ences in the management of overdose events by untrained
rescuers compared to trained rescuers and no significant
evidence of overall change in opioid use after receiving na-
loxone rescue kits.
Trained versus untrained overdose rescuer events
We describe a previously unstudied subset of overdose
rescue reports - those performed by people who had not
been trained by OEND staff at the time of using naloxone
during an overdose. Although we have categorized them
as untrained, these overdose rescuers obtained naloxone
and learned to use it through their social networks, most
likely by others trained in the Massachusetts’ programs.
Our findings are consistent with and compliment a quali-
tative study in Baltimore, among OEND participants (N =
25), which found that educating family and other social
networks members about overdose and naloxone use was
valued by people who use drugs as well as their drug using
and non-drug using social network members and was
more acceptable than discussing how to reduce drug use
behaviors [48]. The diffusion of overdose training and na-
loxone rescue kits is also consistent with a study of PWID
which reported at 3-month follow-up that 40% of trainees
had trained someone else [26]. Several studies have shown
that OEND training improved knowledge [20,49] and
overdose response actions between pre- and post- training
overdose events [36,50]. In this study, however, we found
no substantive differences in overdose rescue management
Table 2 Overdose rescues reported by substance using
bystanders in Massachusetts, 2006-2010
Rescues after
training
Rescues before
training
p-value*
N = 508 N =91
Relationship to overdose
victim
0.92
Friend 67% (341/508) 69% (63/91)
Partner/family 12% (62/508) 13% (12/91)
Stranger 9.1% (46/508) 8.8% (8/91)
Client/patient ** **
Self 10% (53/508) 8.8% (8/91)
Declined ** **
Overdose setting 0.13
Private 79% (395/498) 70% (62/89)
Public 20% (100/498) 29% (26/89)
Declined ** **
Number of doses used 0.06
1 52% (244/468) 61% (52/85)
2 43% (201/468) 39% (33/85)
3+ 4.9% (23/468) 0.0% (0/85)
Naloxone successful 97% (295/303) 96% (54/56) 0.70
911 called or emergency
personnel present
23% (119/508) 27% (25/91) 0.41
Rescue breathing performed 47% (166/350) 52% (34/66) 0.54
Stayed with victim until
alert or help arrived
89% (445/498) 89% (78/88) 0.84
Sternal rub 63% (222/350) 62% (41/66) 0.84
Slap 38% (134/350) 35% (23/66) 0.60
Ice or water 9.4% (33/350) 14% (9/66) 0.30
Salt or cocaine shot 0.0% (0/350) 0.0% (0/66) –
Denominators less than the total number for each group are due to
missing information.
*Categorical variables are compared using a chi square test.
**Cells with values less than 5 suppressed.
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ive studies are warranted to determine how social
network training and dissemination should be for-
mally incorporated into program design. Furthermore,
it is worthwhile to determine the minimum instruc-
tion necessary for a person to appropriately adminis-
ter naloxone while responding to an overdose,
specifically to determine whether naloxone for over-
dose can be safely distributed as an over-the-counter
medication [51]. While this study alone is insufficient
to claim that over-the-counter access to naloxone is
safe and effective, the results support exploration of
this possibility.
Changes in substance use
In the analysis of the subset of participants from whom we
collected substance use information more than once, we
found no clear evidence that heroin use increased more
than decreased among substance using OEND participants.
Heroin was the most commonly used substance among
participants and a sizeable minority used other substances
in the 30 days prior to enrollment. These findings provide
reassurance that training active substance users in over-
dose management and distributing naloxone rescue kits
does not lead opioid users to increase their overall opioid
use. Our findings are consistent with OEND program eval-
uations have showed a decrease in heroin injection [24] or
overall drug use [26] after OEND. Because our study was
completed with program data from participants in a pro-
gram that was widely disseminated in needle exchanges,
drop-in centers and, in particular, substance abuse treat-
ment programs, rather than among a more homogeneous
population of study subjects, it is not surprising that partic-
ipants had substantial flux in their drug use. Nonetheless,
we did not find an overall trend toward increased heroin
use, and the largest group actually decreased heroin use.
For each of the other substances, almost half or more
did not change their use and many participants were not
using substances in addition to heroin at all. Although the
dataset did not distinguish those participants using pre-
scription medications with or without a prescription, it is
possible that participants using prescription medications,
including methadone, buprenorphine, other opioids, or
barbiturates/benzodiazepines who increased their use, did
so because they were engaged in addiction, medical or
mental health treatment and receiving prescriptions for
these medications.
The increase in benzodiazepine/barbiturate use in the
past 30 days was unexpected, because the OEND training
Table 3 Change in substance use among overdose
education and naloxone distribution program participants
between first and second enrollment- number of days and
substances used, past 30 days
N =325 Increased Decreased No change p-value*
Heroin 115 (35%) 122 (38%) 88 (27%) 0.52
Methadone 84 (26%) 70 (22%) 171 (52%) 0.72
Buprenorphine 73 (22%) 66 (20%) 186 (58%) 0.31
Other opioids 59 (18%) 62 (19%) 205 (63%) 0.51
Cocaine 83 (26%) 96 (30%) 146 (44%) 0.41
Alcohol 69 (21%) 70 (22%) 186 (57%) 0.86
Benzo/Barbiturate 99 (30%) 74 (23%) 152 (47%) 0.004
Number of
substances** used
131 (40%) 125 (38%) 69 (21%) 0.65
*Wilcoxon signed rank test which compares the median difference between
two repeated measures among the repeat enrollers.
**Participants were asked about use of heroin, methadone, buprenorphine,
other opioids, cocaine, alcohol, benzodiazepine/barbiturate
and methamphetamine.
Figure 2 Percentage of overdose education and naloxone distribution program participants* reporting substance use, past 30 days.
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benzodiazepine combinations, which is an important risk
for overdose [52]. Benzodiazepines/barbiturates were used
by less than half of participants, yet they were the most
commonly used substances other than heroin. If naloxone
provided a “safety net” for heroin users, it should increase
heroin use, not benzodiazepine/barbiturate use. The per-
centage of people who reported increased benzodiazep-
ine/barbiturate may be the result of a concurrent increase
in benzodiazepine use, as evidenced by an increase in
emergency department visits involving benzodiazepines
[53]. Another explanation may be that people who enrolled
a second time had increased treatment for comorbid men-
tal health disorders which included benzodiazepine/barbit-
urate prescription [54]. The relationship between illicit
opioid use, other sedating medications like benzodiaze-
pines and addiction treatment is complicated by multiple
competing risks and benefits. For example, although de-
toxification can be a first step to treating a substance use
disorder and potentially reducing overdose risk, it often
includes the use of comfort medications, like benzodiaze-
pines that are sedating and increase overdose risk. Fur-
thermore, the period immediately following discharge
from treatment is one of the highest overdose risk times
[55], because opioid tolerance is decreased. Thus the role
that benzodiazepines play in the cycle of substance use
disorder, detoxification, recovery, relapse and overdose is
complicated and warrants further study. OEND programs
should continue to stress the risks of poly substance use
in overdose prevention education.
Limitations
This study has several limitations. While we report on a
larger sample of OEND participants from more diverse
settings compared to previous studies, the study was
conducted among program participants using program
data. Thus, we are not able to compare outcomes to
people who did not receive OEND and therefore are un-
able to measure the impact of receiving OEND, gener-
ally. Among those who were re-enrolled by an OEND
program site and/or reported an overdose rescue while
requesting a naloxone rescue kit refill, the follow-up data
were not collected systematically but rather by conveni-
ence, which implies that both successful and unsuccess-
ful overdose rescue reports are likely an undercount.
The program information we used for our analysis was
not collected for research purposes and it included self-
reported stigmatized, illegal behaviors. Yet, trained staff
collected the data in settings where active substance use
by participants was normative and relationships between
participants and staff often predated OEND implementa-
tion. Neither names nor contact information was collected,
so there were substantial confidentiality protections. There
may have been some social desirability bias in the self-
reporting of substance use because the OEND training in-
cluded messages about reducing use, particularly polysub-
stance use. Yet, the strength of these messages was
unlikely to be substantially stronger at subsequent visits
than at the first visit and the social desirability bias may
be smaller in our program data where collecting infor-
mation was normative as part of providing services
compared to research survey data explicitly collected to
measure changes in behavior. The program dataset did
not distinguish between prescribed and non-prescribed
pharmaceutical substances or the clinical indication for
prescribed substances. While we were able to confirm
that the untrained overdose rescuers (Figure 1) were not
trained by OEND staff, we were unable to assess the
content of the information that untrained rescuers re-
ceived through social networks and the extent to which
the information was similar or different than that pro-
vided by OEND staff. We were unable to account for
environmental factors that may have influenced sub-
stance use and addiction treatment access that occurred
during the study period, such as the implementation of
the Massachusetts health care insurance reform law
(mandatory universal health insurance coverage) begin-
ning in 2006, expanded access to MDPH supported
buprenorphine treatment in 2006–8, restrictions on distri-
bution of 40 mg methadone for pain in 2008, and refor-
mulation of OxyContin in the fall of 2010 [56]. Finally, we
sought to highlight important research questions related
to OEND, but prospective studies are required to fully re-
spond to these questions.
Conclusion
Overdose education and naloxone distribution (OEND) in
Massachusetts is an overdose prevention intervention that
has been widely implemented by nonmedical public health
workers among thousands of people who use drugs and
have high drug overdose risk. These high risk drug users
have witnessed and successfully responded to hundreds of
overdoses. We found few differences in behavior between
trained and untrained opioid overdose rescuers, which
may warrant consideration of over-the-counter status for
naloxone rescue kits in future prospective investigations.
We found no clear evidence among participants of overall
increased heroin use upon receiving comprehensive OEND
services. Randomized controlled trials or prospective
cohort studies of OEND with systematic and thorough
follow-up are the needed next steps in addressing the
structure, content and optimal amount of training to ac-
company naloxone rescue kits and the effect of OEND on
participant drug use. Information and naloxone dissemin-
ation among social networks also warrants more investiga-
tion. Further study is also needed to understand the
nuanced relationship between non-opioid sedating medi-
cations and opioid overdose. Nonetheless, concern about
Doe-Simkins et al. BMC Public Health 2014, 14:297 Page 9 of 11
http://www.biomedcentral.com/1471-2458/14/297increased substance use should not impede the study and
expansion of OEND programs or policies, legislation or
regulations that support them.
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